Clinical Trial: A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364877) titled 'A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers' on Jan. 06.

Brief Summary: Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S

Study Start Date: Dec. 28, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Adult Volunteer

Intervention: DRUG: DW4421

DW4421 or DW4421S

DRUG: DW4421S

DW4421 or DW4421S

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Daewon Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....